JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS

metrics 2024

Empowering Research in Cancer and Beyond.

Introduction

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, published by BIOLIFE SAS, is a pivotal platform in the fields of Cancer Research, Endocrinology, Immunology, and Physiology, addressing fundamental aspects of biological regulation and homeostasis. Since its inception in 1987, this journal has consistently contributed to the advancement of knowledge, showcasing innovative research and breakthroughs that are instrumental for professionals, researchers, and students alike. Although categorized in the Q4 quartile across multiple disciplines, the journal offers a unique perspective that encourages exploration into underrepresented areas, underscoring its role in fostering scientific dialogue and collaboration. With ISSN 0393-974X and E-ISSN 1724-6083, the journal remains a crucial resource for those invested in understanding the complexities of homeostatic agents and their implications in health and disease. Based in Silva Marina, Italy, it invites contributions that broaden the horizons of contemporary biomedical research.

Metrics 2024

SCIMAGO Journal Rank0.23
Journal Impact Factor0.80
Journal Impact Factor (5 years)1.30
H-Index56
Journal IF Without Self0.80
Eigen Factor0.00
Normal Eigen Factor0.52
Influence0.20
Immediacy Index0.10
Cited Half Life5.10
Citing Half Life4.90
JCI0.17
Total Documents4081
WOS Total Citations2954
SCIMAGO Total Citations15680
SCIMAGO SELF Citations2335
Scopus Journal Rank0.23
Cites / Document (2 Years)0.61
Cites / Document (3 Years)0.96
Cites / Document (4 Years)0.95

Metrics History

Rank 2024

Scopus

Oncology in Medicine
Rank #270/404
Percentile 33.17
Quartile Q3
Endocrinology, Diabetes and Metabolism in Medicine
Rank #169/244
Percentile 30.74
Quartile Q3
Physiology (medical) in Medicine
Rank #80/113
Percentile 29.20
Quartile Q3
Immunology and Allergy in Medicine
Rank #171/233
Percentile 26.61
Quartile Q3
Immunology in Immunology and Microbiology
Rank #185/236
Percentile 21.61
Quartile Q4
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #182/230
Percentile 20.87
Quartile Q4
Endocrinology in Biochemistry, Genetics and Molecular Biology
Rank #105/128
Percentile 17.97
Quartile Q4
Physiology in Biochemistry, Genetics and Molecular Biology
Rank #160/193
Percentile 17.10
Quartile Q4

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 161/186
Percentile 13.70
Quartile Q4
IMMUNOLOGY
Rank 172/181
Percentile 5.20
Quartile Q4
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 162/189
Percentile 14.60
Quartile Q4
PHYSIOLOGY
Rank 79/85
Percentile 7.60
Quartile Q4

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 164/186
Percentile 11.83
Quartile Q4
IMMUNOLOGY
Rank 171/181
Percentile 5.52
Quartile Q4
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 165/189
Percentile 12.70
Quartile Q4
PHYSIOLOGY
Rank 80/85
Percentile 5.88
Quartile Q4

Quartile History

Similar Journals

POSTEPY BIOLOGII KOMORKI

Elevating Understanding in Cellular and Anatomical Research
Publisher: POLSKIE TOWARZYSTWO ANATOMICZNEISSN: 0324-833XFrequency: 4 issues/year

POSTĘPY BIOLOGII KOMÓRKI is a pivotal journal in the field of cell biology, published by the renowned Polskie Towarzystwo Anatomiczne. Since its inception, this journal has been dedicated to advancing scientific knowledge through the dissemination of high-quality research articles, reviews, and original studies focused on cellular structure and function. Although POSTĘPY BIOLOGII KOMÓRKI does not currently operate as an open-access journal, it remains a significant resource for researchers and professionals alike, contributing to critical discussions and findings in the biological sciences. The journal has undergone coverage discontinuation in Scopus, yet it continues to serve as an essential platform in Poland for scholarly exchange in cellular and anatomical research. Situated at the Centrum Medyczne Kształcenia Podyplomowego in Warsaw, it aims to bridge gaps in understanding and nurture academic growth among students and professionals in the biological sciences.

JOURNAL OF GENE MEDICINE

Bridging Laboratory Discoveries with Clinical Applications
Publisher: WILEYISSN: 1099-498XFrequency: 12 issues/year

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

GENERAL AND COMPARATIVE ENDOCRINOLOGY

Pioneering insights into the endocrine landscape since 1961.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0016-6480Frequency: 15 issues/year

GENERAL AND COMPARATIVE ENDOCRINOLOGY, published by Academic Press Inc Elsevier Science, is a distinguished journal that has been at the forefront of endocrine research since its inception in 1961. With an ISSN of 0016-6480 and an E-ISSN of 1095-6840, this journal caters to a diverse audience, including researchers, professionals, and students in the fields of animal science, zoology, and endocrinology. It holds a prestigious Q1 ranking in Animal Science and Zoology and is recognized in the Q3 quartile for Endocrinology, indicating its significant contribution to advancing scientific knowledge. The journal is also well-regarded within the Scopus rankings, with impressive placements in multiple categories, highlighting its impact and relevance in the academic community. By focusing on comparative analyses and fostering a deeper understanding of hormone function and regulation across species, GENERAL AND COMPARATIVE ENDOCRINOLOGY aims to bridge gaps in knowledge and stimulate innovative research paradigms. While it does not currently offer Open Access, the journal remains committed to high-quality peer-reviewed content, making it an essential resource for anyone engaged in this vital field of study.

FASEB BioAdvances

Connecting Researchers Through Open Access Science
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

MOLECULAR THERAPY

Connecting researchers to reshape the future of medicine.
Publisher: CELL PRESSISSN: 1525-0016Frequency: 12 issues/year

MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.

BIOLOGICAL PROCEDURES ONLINE

Fostering Collaboration in the Evolving World of Biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.

Doklady Biochemistry and Biophysics

Unveiling the Complexities of Biological Systems Through Rigorous Research
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Synthesis of Ideas for Tomorrow’s Genetic Discoveries
Publisher: BEGELL HOUSE INCISSN: 1045-4403Frequency: 3 issues/year

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, published by BEGELL HOUSE INC, serves as a vital resource within the fields of Genetics and Molecular Biology. With the ISSN 1045-4403 and E-ISSN 2162-6502, this journal has been contributing to scientific discourse since 1990 and is projected to continue its publication until 2024. Despite its classification in the Q3 quartile for both Genetics and Molecular Biology, its impact on the research community is significant, as evidenced by its diverse range of critical reviews that synthesize and analyze emerging trends and foundational studies in gene expression. The journal, located in the United States at 50 North St, Danbury, CT 06810, offers a platform for researchers, professionals, and students to engage with innovative ideas and methodologies that drive forward the understanding of gene regulatory mechanisms in eukaryotes. Although it currently does not offer open access, the journal's content remains crucial for those dedicated to advancing knowledge in the intricacies of genetic expression.

CELLULAR AND MOLECULAR BIOLOGY

Connecting Researchers in Cellular Dynamics
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Exploring the molecular mechanisms that shape our world.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.